GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
105 hedge funds and large institutions have $68.8M invested in Sanofi Contingent Value Rights in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
6% less capital invested
Capital invested by funds: $73.1M → $68.8M (-$4.28M)
Holders
105
Holding in Top 10
2
Calls
$15.8M
Puts
–
Top Buyers
| 1 | +$415K | |
| 2 | +$147K | |
| 3 | +$93.6K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$64.7K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$51.4K |
Top Sellers
| 1 | -$558K | |
| 2 | -$23K | |
| 3 | -$10.9K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$7.4K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.44K |